In a previous series of advanced ovarian cancer, we showed that patients with lower levels of baseline NLR had better DFS in both BRCA mutated and wild type groups (with borderline significance in the wild type group) [ 23 ].
← all excerpts
The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer.
1
—
—